Can you provide the average price target for BP PLC-SPONS ADR stock?
33 analysts have analysed BP and the average price target is 39.39 USD. This implies a price decrease of -9.79% is expected in the next year compared to the current price of 43.67.
NYSE:BP • US0556221044
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BP PLC-SPONS ADR (BP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-20 | HSBC | Upgrade | Reduce -> Hold |
| 2026-03-12 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-02-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-08 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-06 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-11-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-11-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-17 | Wells Fargo | Initiate | Equal-Weight |
| 2025-10-17 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-09 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-09-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-09-15 | Exane BNP Paribas | Upgrade | Neutral -> Outperform |
| 2025-08-20 | Melius Research | Initiate | Buy |
| 2025-08-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-14 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2025-07-15 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-06-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-19 | Jefferies | Downgrade | Buy -> Hold |
| 2025-05-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-19 | TD Securities | Downgrade | Buy -> Hold |
| 2025-02-20 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-02-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-17 | Raymond James | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 210.13B -12.95% | 189.185B -9.97% | 189.335B 0.08% | 187.991B -0.71% | 189.482B 0.79% | 186.045B -1.81% | 213.054B 14.52% | 217.314B 2.00% | N/A | N/A | |
| EBITDA YoY % growth | 46.288B -16.54% | 29.521B -36.22% | 33.661B 14.02% | 34.777B 3.32% | 35.858B 3.11% | 36.302B 1.24% | 37.114B 2.24% | 39.913B 7.54% | N/A | N/A | |
| EBIT YoY % growth | 30.36B -26.21% | 12.899B -57.51% | 15.496B 20.13% | 20.119B 29.83% | 18.893B -6.09% | 19.834B 4.98% | 19.946B 0.56% | 20.17B 1.12% | 27.874B 38.20% | 28.501B 2.25% | |
| Operating Margin | 14.45% | 6.82% | 8.18% | 10.70% | 9.97% | 10.66% | 9.36% | 9.28% | N/A | N/A | |
| EPS YoY % growth | 4.75 -45.14% | 3.24 -31.77% | 2.84 -12.43% | 2.69 -5.34% | 3.24 20.66% | 3.46 6.73% | 3.82 10.41% | 4.10 7.31% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.84 74.89% | 0.67 -25.27% | 0.76 -10.61% | 0.77 28.25% | 0.73 -13.84% | 0.80 18.68% | 0.43 -43.21% | 0.82 6.50% | 0.66 -8.91% | 0.78 -1.91% | 0.81 87.14% |
| Revenue Q2Q % growth | 52.508B 9.67% | 44.072B -7.56% | 37.248B -24.37% | 46.233B -3.16% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 9.881B 20.91% | 9.062B -30.99% | 8.963B -50.19% | 9.257B -56.28% | 8.779B -11.15% | 9.07B 0.09% | 9.188B 2.51% | 8.97B -3.10% | 8.535B -2.78% | 8.938B -1.46% | 9.094B -1.02% |
| EBIT Q2Q % growth | 5.594B 42.12% | 4.632B 11.03% | 4.609B 5.23% | 5.133B 70.64% | 5.87B 4.93% | 5.926B 27.94% | 6.018B 30.57% | 6.028B 17.44% | N/A | N/A | N/A |
All data in USD
33 analysts have analysed BP and the average price target is 39.39 USD. This implies a price decrease of -9.79% is expected in the next year compared to the current price of 43.67.
BP PLC-SPONS ADR (BP) will report earnings on 2026-04-28, before the market open.
The consensus EPS estimate for the next earnings of BP PLC-SPONS ADR (BP) is 0.84 USD and the consensus revenue estimate is 52.51B USD.
The expected long term growth rate for BP PLC-SPONS ADR (BP) is -0.43%.